Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor recep…
Biotechnology
US, Redwood City [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Bolt Biotherapeutics, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDBolt Biotherapeutics, Inc. can't present revenue by segment